is a cutting-edge treatment that delivers the hTERT gene into human cells (usually using AAV virus) to reactivate telomerase production, which extends telomere length, delays cellular aging, and helps restore youthful cell function.

uses a harmless virus (typically AAV) to deliver the follistatin gene into muscle cells, where it produces high levels of follistatin protein that blocks myostatin — the natural “brake” on muscle growth — resulting in significantly increased muscle mass, strength, and regeneration.

Bacterial plasmid gene therapy (also called non-viral gene therapy) involves introducing a circular piece of DNA called a plasmid that carries a therapeutic gene into human gut then this plasmid serves as a blueprint to produce the desired protein.

is a fast, automated drug discovery technique that allows scientists to rapidly test tens or hundreds of thousands of chemical compounds in laboratory assays to identify which ones actively affect a specific target (such as activating the hTERT gene), dramatically accelerating the discovery of new drug candidates.